Steven W. Spector

2014

In 2014, Steven W. Spector earned a total compensation of $1.8M as Executive Vice President, General Counsel and Secretary at Arena Pharmaceuticals, a 20% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$163,925
Option Awards$191,490
Salary$415,000
Stock Awards$1,059,600
Other$16,320
Total$1,846,335

Spector received $1.1M in stock awards, accounting for 57% of the total pay in 2014.

Spector also received $163.9K in non-equity incentive plan, $191.5K in option awards, $415K in salary and $16.3K in other compensation.

Rankings

In 2014, Steven W. Spector's compensation ranked 4,846th out of 13,032 executives tracked by ExecPay. In other words, Spector earned more than 62.8% of executives.

ClassificationRankingPercentile
All
4,846
out of 13,032
63rd
Division
Manufacturing
1,732
out of 4,966
65th
Major group
Chemicals And Allied Products
567
out of 1,686
66th
Industry group
Drugs
433
out of 1,365
68th
Industry
Pharmaceutical Preparations
345
out of 1,043
67th
Source: SEC filing on April 28, 2017.

Spector's colleagues

We found six more compensation records of executives who worked with Steven W. Spector at Arena Pharmaceuticals in 2014.

2014

Jack Lief

Arena Pharmaceuticals

Chief Executive Officer

2014

Dominic Behan

Arena Pharmaceuticals

Chief Scientific Officer

2014

William Shanahan

Arena Pharmaceuticals

Chief Medical Officer

2014

Robert Hoffman

Arena Pharmaceuticals

Chief Financial Officer

2014

Craig Audet

Arena Pharmaceuticals

Former Senior Vice President, Operations and Head of Global Regulatory Affairs

2014

Harry Hixson

Arena Pharmaceuticals

Chief Executive Officer

You may also like